Leukemia, Myelodysplasia, Transplantation
Reviews
Implications of Improved Survival in Patients With Chronic Myeloid Leukemia: A Nursing Perspective
News
Blinatumomab Induces Complete Remissions in Acute Lymphoblastic Leukemia
Major Finding: A total of 9 of 12 patients with relapsed B-precursor acute lymphoblastic leukemia who received blinatumomab 5 mcg/m2 per day for 1...
Original Report
The impact of myelodysplastic syndromes on quality of life: lessons learned from 70 voices
How We Do It
Managing Side Effects of Tyrosine Kinase Inhibitor Therapy to Optimize Adherence in Patients with Chronic Myeloid Leukemia: The Role of the Midlevel Practitioner
News
Many Elderly AML Patients Not Receiving Chemotherapy
Major Finding: More than half of elderly patients (56%) with AML received only best supportive care post diagnosis, Data Source: A study of 6,888...
News
New Genetic Markers May Tailor Leukemia Treatment
Major Finding: Genetic alterations were identified in 11 of 12 patients that can be targeted with existing therapies.Data Source: Genomic and...
News
BTK Inhibitor Draws High Response Rate in CLL
Major Finding: At 10.2 months’ median follow-up, 70% of 27 patients with chronic lymphocytic leukemia/small lymphocytic lymphoma assigned to a 420...
News
Gemtuzumab Extends Survival in Acute Myeloid Leukemia
Major Finding: Overall survival increased from 19 months in the standard treatment group to 34 months in patients given gemtuzumab ozogamicin.Data...
Conference Coverage
Study Characterizes Spectrum of Somatic Mutations in Chronic Lymphocytic Leukemia
Major Finding: The nine driver genes identified in this study appear in five core signaling pathways, and the genes each play different, though...
News
Stem Cell Transplant: Physical, Mental Health Burdens Persist
Major Finding: 74% of hematopoietic cell transplant survivors reported having any chronic health condition at least 10 years, compared with 39%of...
News
PBSC Transplants from Unrelated Donors Show No Survival Advantage
Major Finding: Two-year overall survival among 273 patients randomized to receive peripheral-blood stem cells from an unrelated donor was 51% in...